The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT06046482
Brief Title: Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma
First Submitted : September 14, 2023
First Submitted that Met QC Criteria : September 14, 2023
First Posted : September 21, 2023
Last Update Submitted that Met QC Criteria : April 11, 2024
Last Update Posted : April 12, 2024